Javascript must be enabled to continue!
Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period
View through CrossRef
Abstract
Aim
Evaluation the levels of markers having highest prediction value regarding the risk of death in patients with STEMI and NSTEMI in 1 year after angioplasty.
Material and methods
The study enrolled 558 patients with STEMI and 553 pts with NSTEMI. From those who dead and survived 4 groups of pts have been selected by equal number 75 and homogenous concerning gender, age, comorbidities, cardiovascular risk factors and time of culprit coronary artery (s) revascularization. 62 markers referring to inflammation, endothelial and hemostasis dysfunction, NETosis, neuroendocrine activity and oxidative stress, cell injury and cardiovascular remodeling have been determined at admission (before coronary angioplasty) and at 24th hour after. Prediction power of markers regarding death risk was estimated by Odd’s ratio.
Results
Mortality rate was 17,03% (95 pts) in STEMI, and 14,8% (82 pts) in NSTEMI. In concern to Odd’s ratio having highest and similar power of death prediction should be emphasized following 9 markers determined at admission: IL-1β, selectin-E, endocan, von Willebrand/ADAMTS13 ratio, platelets microvesicles (CD62P), neutrophil elastase, myeloperoxidase, Ang 1-7/Ang II ratio and GDF-15. The Odd’s ratio of these markers was in a range of 2.26-2.97 (CI p<0,001). Remarkable, that in dead pts only have been found circulating activator autoantibodies against receptor ETA of ET-1 in 21 pts of STEMI (22.1%) and 16 pts of NSTEMI (19.5%). Noteworthy, in the top of reperfusion outrage on myocardium (first 24 hours) the increment of ischemia modified albumin (IMA) and H-FABP was significantly higher in dead vs survivors. More than that, the increasing ratio of these markers was higher in NSTEMI vs STEMI: 88.5 and 104.8% vs 65.5 and 85.2%, what in principle confirms the Heusch’s hypothesis viewing ischemic precondition influence on myocardial damage inherent to reperfusion impact.
Conclusion
Our study underlined at admission 9 circulating markers demonstrating a highest and similar Odd’s ratio of death risk in pts with either STEMI of NSTEMI which conceptually could be linked to key mechanisms of coronary microcirculatory dysfunction. Likewise, the increment of IMA and H-FABP from admission to 24 hours may reliably predict risk of death, and its higher level in NSTEMI indicates a more considerable contribution of reperfusion impact on myocardial damage in comparison with STEMI.
Oxford University Press (OUP)
Title: Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period
Description:
Abstract
Aim
Evaluation the levels of markers having highest prediction value regarding the risk of death in patients with STEMI and NSTEMI in 1 year after angioplasty.
Material and methods
The study enrolled 558 patients with STEMI and 553 pts with NSTEMI.
From those who dead and survived 4 groups of pts have been selected by equal number 75 and homogenous concerning gender, age, comorbidities, cardiovascular risk factors and time of culprit coronary artery (s) revascularization.
62 markers referring to inflammation, endothelial and hemostasis dysfunction, NETosis, neuroendocrine activity and oxidative stress, cell injury and cardiovascular remodeling have been determined at admission (before coronary angioplasty) and at 24th hour after.
Prediction power of markers regarding death risk was estimated by Odd’s ratio.
Results
Mortality rate was 17,03% (95 pts) in STEMI, and 14,8% (82 pts) in NSTEMI.
In concern to Odd’s ratio having highest and similar power of death prediction should be emphasized following 9 markers determined at admission: IL-1β, selectin-E, endocan, von Willebrand/ADAMTS13 ratio, platelets microvesicles (CD62P), neutrophil elastase, myeloperoxidase, Ang 1-7/Ang II ratio and GDF-15.
The Odd’s ratio of these markers was in a range of 2.
26-2.
97 (CI p<0,001).
Remarkable, that in dead pts only have been found circulating activator autoantibodies against receptor ETA of ET-1 in 21 pts of STEMI (22.
1%) and 16 pts of NSTEMI (19.
5%).
Noteworthy, in the top of reperfusion outrage on myocardium (first 24 hours) the increment of ischemia modified albumin (IMA) and H-FABP was significantly higher in dead vs survivors.
More than that, the increasing ratio of these markers was higher in NSTEMI vs STEMI: 88.
5 and 104.
8% vs 65.
5 and 85.
2%, what in principle confirms the Heusch’s hypothesis viewing ischemic precondition influence on myocardial damage inherent to reperfusion impact.
Conclusion
Our study underlined at admission 9 circulating markers demonstrating a highest and similar Odd’s ratio of death risk in pts with either STEMI of NSTEMI which conceptually could be linked to key mechanisms of coronary microcirculatory dysfunction.
Likewise, the increment of IMA and H-FABP from admission to 24 hours may reliably predict risk of death, and its higher level in NSTEMI indicates a more considerable contribution of reperfusion impact on myocardial damage in comparison with STEMI.
Related Results
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Introduction: Acute myocardial infarction remains a leading cause of cardiovascular mortality worldwide [1 ]. However, ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI) pati...
Subfatin concentration decreases in acute coronary syndrome
Subfatin concentration decreases in acute coronary syndrome
We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NST...
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Introduction:
Serum troponin is a ubiquitous biomarker used to diagnose acute myocardial infarction (AMI). The positive predictive value (PPV) of high-sensitivity tropo...
342 Impact of temporary traffic bans on the risk of acute coronary syndromes in a large metropolitan area
342 Impact of temporary traffic bans on the risk of acute coronary syndromes in a large metropolitan area
Abstract
Aims
Strong epidemiologic evidence has highlighted the role of pollution, on top of adverse climate features, as a nove...
Shock Index and Modified Shock Index Are Predictors of Long-Term Mortality in STEMI and NSTEMI Patients
Shock Index and Modified Shock Index Are Predictors of Long-Term Mortality in STEMI and NSTEMI Patients
Background: Acute coronary syndromes (ACS), including STEMI and NSTEMI, are leading causes of mortality worldwide. The Shock Index (SI) and Modified Shock Index (MSI) are non-invas...
Neutrophil Dynamics in Acute Coronary Syndrome
Neutrophil Dynamics in Acute Coronary Syndrome
Aims: Clinical evidence indicates that innate immune cells may contribute to the onset and outcome of acute coronary syndrome (ACS). Our prospective study aimed at analysing neutro...
Diagnosis and management of non-STEMI coronary syndromes
Diagnosis and management of non-STEMI coronary syndromes
Abstract
Acute coronary syndromes are classified as ST segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) or unstable angina. Most patients with NST...
Predictors of 1-year follow-up period MACE in patients with NSTEMI
Predictors of 1-year follow-up period MACE in patients with NSTEMI
Abstract
Background
Identifying viable predictors of MACE in NSTEMI continues to pose a challenge in the field of cardiology. Un...

